Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jai-Hee Moon

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Asian Pacific Journal of Cancer Prevention : APJCP|March 8, 2013
Iris Nertschinskia ethanol extract differentially induces cytotoxicity in human breast cancer cells depending on AKT1/2 activityJae-Sik Shin, Hyung-Gun Maeng, Seung-Woo Hong, et al.
Apoptosis : an International Journal on Programmed Cell Death|March 22, 2014
NVP-BEZ235, a dual PI3K/mTOR inhibitor, induces cell death through alternate routes in prostate cancer cells depending on the PTEN genotypeSeung-Woo Hong, Jae-Sik Shin, Jai-Hee Moon, et al.
Free Radical Biology & Medicine|March 26, 2016
L-Ascorbic acid can abrogate SVCT-2-dependent cetuximab resistance mediated by mutant KRAS in human colon cancer cellsSoo-A Jung, Dae-Hee Lee, Jai-Hee Moon, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 24, 2015
SAHA, an HDAC inhibitor, overcomes erlotinib resistance in human pancreatic cancer cells by modulating E-cadherinSeong Joon Park, Seung-Mi Kim, Jai-Hee Moon, et al.
Investigational New Drugs|November 1, 2013
NPS-1034, a novel MET inhibitor, inhibits the activated MET receptor and its constitutively active mutantsJae-Sik Shin, Seung-Woo Hong, Jai-Hee Moon, et al.
Oncotarget|August 29, 2015
A novel small-molecule IAP antagonist, AZD5582, draws Mcl-1 down-regulation for induction of apoptosis through targeting of cIAP1 and XIAP in human pancreatic cancerJai-Hee Moon, Jae-Sik Shin, Seung-Woo Hong, et al.
Molecular Cancer Therapeutics|September 10, 2015
Targeting FGFR Pathway in Human Hepatocellular Carcinoma: Expressing pFGFR and pMET for Antitumor ActivityJae-Cheol Jo, Eun Kyoung Choi, Jae-Sik Shin, et al.
British Journal of Cancer|April 5, 2019
Targeting β-catenin overcomes MEK inhibition resistance in colon cancer with KRAS and PIK3CA mutationsJai-Hee Moon, Seung-Woo Hong, Jeong Eun Kim, et al.
Investigational New Drugs|May 29, 2020
Chemosensitivity to HM90822, a novel synthetic IAP antagonist, is determined by p-AKT-inducible XIAP phosphorylation in human pancreatic cancer cellsSeung-Woo Hong, Jae-Sik Shin, Jai-Hee Moon, et al.
Anticancer Research|March 29, 2022
CJ14939, a Novel JAK Inhibitor, Increases Oxaliplatin-induced Cell Death Through JAK/STAT Pathway in Colorectal CancerJun Ki Hong, DO Yeon Kim, Jae-Sik Shin, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Asian Pacific Journal of Cancer Prevention : APJCP|March 8, 2013
Iris Nertschinskia ethanol extract differentially induces cytotoxicity in human breast cancer cells depending on AKT1/2 activityJae-Sik Shin, Hyung-Gun Maeng, Seung-Woo Hong, et al.
Apoptosis : an International Journal on Programmed Cell Death|March 22, 2014
NVP-BEZ235, a dual PI3K/mTOR inhibitor, induces cell death through alternate routes in prostate cancer cells depending on the PTEN genotypeSeung-Woo Hong, Jae-Sik Shin, Jai-Hee Moon, et al.
Free Radical Biology & Medicine|March 26, 2016
L-Ascorbic acid can abrogate SVCT-2-dependent cetuximab resistance mediated by mutant KRAS in human colon cancer cellsSoo-A Jung, Dae-Hee Lee, Jai-Hee Moon, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 24, 2015
SAHA, an HDAC inhibitor, overcomes erlotinib resistance in human pancreatic cancer cells by modulating E-cadherinSeong Joon Park, Seung-Mi Kim, Jai-Hee Moon, et al.
Investigational New Drugs|November 1, 2013
NPS-1034, a novel MET inhibitor, inhibits the activated MET receptor and its constitutively active mutantsJae-Sik Shin, Seung-Woo Hong, Jai-Hee Moon, et al.
Oncotarget|August 29, 2015
A novel small-molecule IAP antagonist, AZD5582, draws Mcl-1 down-regulation for induction of apoptosis through targeting of cIAP1 and XIAP in human pancreatic cancerJai-Hee Moon, Jae-Sik Shin, Seung-Woo Hong, et al.
Molecular Cancer Therapeutics|September 10, 2015
Targeting FGFR Pathway in Human Hepatocellular Carcinoma: Expressing pFGFR and pMET for Antitumor ActivityJae-Cheol Jo, Eun Kyoung Choi, Jae-Sik Shin, et al.
British Journal of Cancer|April 5, 2019
Targeting β-catenin overcomes MEK inhibition resistance in colon cancer with KRAS and PIK3CA mutationsJai-Hee Moon, Seung-Woo Hong, Jeong Eun Kim, et al.
Investigational New Drugs|May 29, 2020
Chemosensitivity to HM90822, a novel synthetic IAP antagonist, is determined by p-AKT-inducible XIAP phosphorylation in human pancreatic cancer cellsSeung-Woo Hong, Jae-Sik Shin, Jai-Hee Moon, et al.
Anticancer Research|March 29, 2022
CJ14939, a Novel JAK Inhibitor, Increases Oxaliplatin-induced Cell Death Through JAK/STAT Pathway in Colorectal CancerJun Ki Hong, DO Yeon Kim, Jae-Sik Shin, et al.
Pageof 5